The Global NASH Council in the News

People with metabolic dysfunction-associated fatty liver disease (MASLD) benefit from physical activity. But incorporating regular physical activity into the daily routines of patients with MASLD can be challenging due to time limitations and accessibility issues. These challenges are further compounded by the fatigue associated with MASLD. To support individuals with MASLD in initiating and maintaining...Continue reading→

Members of the Global NASH/MASH Council (GNC) are helping reframe Steatotic Liver Disease as a dynamic and evolving spectrum. In a recently published letter, Drs. Zobair M. Younossi, Shira Zelber-Sagi and Aleksander Krag share their expert insights on the future of this significant liver disease. Their perspective highlights the urgent need for a unified approach...Continue reading→

The Global NASH/MASH Council (GNC) convened a highly productive meeting during the 33rd Annual Conference of the Indian National Association for the Study of the Liver (INASL), held August 7–10, 2025, in Chandigarh, India. Focusing on the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in South and Southeast Asia,...Continue reading→

The Global NASH/MASH Council is delighted to collaborate with Dimer Diabetes 2025 which is a scientific meeting in Bodrum, Turkey with exceptional faculty and agenda. For more information about Dimer Diabetes 2025, please use the following link. https://www.dimerdiabetescenter.com/

GNC and GLC had another very successful meeting during ILC 2025 with over 70 members participating. The meeting was full of exciting reports related to the projects of different GNC/GLC committees. Additionally, an in-depth 3 hours meeting was dedicated to MASLD/SLD discussing NIT algorithms in clinical practice, awareness challenges, patient perspective about MASLD, preventive hepatology...Continue reading→

The Global NASH/MASH Council (GNC) has just published in Gastroenterology (April 11, 2025, In Press) the most comprehensive recommendations about MASLD and MASH. After systematically reviewing 61 guidelines and similar documents (2018-2025) and undertaking an extensive Delphi process, the Global Recommendations for MASLD/MASH provide the most updated clinically relevant information on all aspects of MASLD/MASH including risk...Continue reading→

The Global NASH/MASH Council (GNC) meeting was held during APASL 2025 in Beijing, China. The meeting was co-chaired by Professor Zobair M. Younossi and Professor Jiangao Fan and was attended by over 50 members in person and another 12 via zoom. A number of important topics related to the disease burden, NITs, risk stratification and...Continue reading→

Multidisciplinary management of patients with MASH discussed by Drs Zobair Younossi, Manal Abdelmalek, Christos Montzoros, Mandeep Bajaj and Scott Issacs during the MASH session of Liver Connect 2025.

Today, Dr. Zobair Younossi, Chairman of Global NASH/ MASH Council and President of Chronic Liver Disease Foundation kicked off the 5th Annual Liver Connect meeting in San Antonio Texas. Liver Connect has become a highly popular liver meeting in the US with over 500 attendees.

The Fifth Annual Liver Connect is being organized by Chronic Liver Disease Foundation (CLDF) in San Antonio, Texas (March 20-22,2025). This superb meeting covers cutting-edge information about most common liver diseases (MASH, viral hepatitis, ALD, cholestatic liver disease, complications of cirrhosis, HCC and pediatric liver disease) delivered by internationally renowned experts. The meeting will provide an opportunity...Continue reading→